東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Regulating human embryonic stem cell...

Jiang, Li.

FindBook

Google Book

Amazon

博客來

Regulating human embryonic stem cell in China = a comparative study on human embryonic stem cell's patentability and morality in US and EU /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Regulating human embryonic stem cell in China/ by Li Jiang.
其他題名:	a comparative study on human embryonic stem cell's patentability and morality in US and EU /
作者:	Jiang, Li.
出版者:	Singapore :Springer Singapore : : 2016.,
面頁冊數:	xviii, 200 p. :ill., digital ;24 cm.
內容註:	Values of Human Embryonic Stem Cell Research, the phenomenon of "Stem Cell Tourism" and Inadequate regulation of Human Embryonic Stem Cell in China -- The Moral Maze In Human Embryonic Stem Cell Research: the moral status of human embryo and the moral source of human embryonic stem cell -- China: inconsistent moral standards of human embryonic stem cell research between patent law and practical application -- The United States: Inconsistent policies on federal funding control of human embryonic stem cell research -- The European Union: Inconsistent interpretations of moral provisions in Patent Convention addressing human embryonic stem cell research -- A proposal for controlling human embryonic stem cell research in China: regulate research itself in a reconciled human embryonic stem cell regulation at the international regime.
Contained By:	Springer eBooks
標題:	Embryonic stem cells - Research - China. -
電子資源:	http://dx.doi.org/10.1007/978-981-10-2101-5
ISBN:	9789811021015

Regulating human embryonic stem cell in China = a comparative study on human embryonic stem cell's patentability and morality in US and EU /
Jiang, Li.

Regulating human embryonic stem cell in Chinaa comparative study on human embryonic stem cell's patentability and morality in US and EU /[electronic resource] :by Li Jiang. - Singapore :Springer Singapore :2016. - xviii, 200 p. :ill., digital ;24 cm.

Values of Human Embryonic Stem Cell Research, the phenomenon of "Stem Cell Tourism" and Inadequate regulation of Human Embryonic Stem Cell in China -- The Moral Maze In Human Embryonic Stem Cell Research: the moral status of human embryo and the moral source of human embryonic stem cell -- China: inconsistent moral standards of human embryonic stem cell research between patent law and practical application -- The United States: Inconsistent policies on federal funding control of human embryonic stem cell research -- The European Union: Inconsistent interpretations of moral provisions in Patent Convention addressing human embryonic stem cell research -- A proposal for controlling human embryonic stem cell research in China: regulate research itself in a reconciled human embryonic stem cell regulation at the international regime.

The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal control are inefficient and ineffective way to monitoring human embryonic stem cell research. The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime. The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonic stem cell research.

ISBN: 9789811021015

Standard No.: 10.1007/978-981-10-2101-5doiSubjects--Topical Terms:

2210284
Embryonic stem cells
--Research--China.

LC Class. No.: KNQ3098.5 / .J53 2016

Dewey Class. No.: 344.5104196

Regulating human embryonic stem cell in China = a comparative study on human embryonic stem cell's patentability and morality in US and EU /
LDR:02836nmm a2200313 a 4500 001 2047993
003 DE-He213
005 20160801184252.0
006 m d
007 cr nn 008maaau
008 170319s2016 si s 0 eng d
020 $a 9789811021015 $q (electronic bk.)
020 $a 9789811021008 $q (paper)
024 7 $a 10.1007/978-981-10-2101-5 $2 doi
035 $a 978-981-10-2101-5
040 $a GP $c GP
041 0 $a eng
050 4 $a KNQ3098.5 $b .J53 2016
072 7 $a LNTM $2 bicssc
072 7 $a LAW093000 $2 bisacsh
082 0 4 $a 344.5104196 $2 23
090 $a KNQ3098.5 $b .J61 2016
100 1 $a Jiang, Li. $3 1909279
245 1 0 $a Regulating human embryonic stem cell in China $h [electronic resource] : $b a comparative study on human embryonic stem cell's patentability and morality in US and EU / $c by Li Jiang.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2016.
300 $a xviii, 200 p. : $b ill., digital ; $c 24 cm.
505 0 $a Values of Human Embryonic Stem Cell Research, the phenomenon of "Stem Cell Tourism" and Inadequate regulation of Human Embryonic Stem Cell in China -- The Moral Maze In Human Embryonic Stem Cell Research: the moral status of human embryo and the moral source of human embryonic stem cell -- China: inconsistent moral standards of human embryonic stem cell research between patent law and practical application -- The United States: Inconsistent policies on federal funding control of human embryonic stem cell research -- The European Union: Inconsistent interpretations of moral provisions in Patent Convention addressing human embryonic stem cell research -- A proposal for controlling human embryonic stem cell research in China: regulate research itself in a reconciled human embryonic stem cell regulation at the international regime.
520 $a The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal control are inefficient and ineffective way to monitoring human embryonic stem cell research. The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime. The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonic stem cell research.
650 0 $a Embryonic stem cells $x Research $x Law and legislation $z China. $3 2210284
650 0 $a Embryonic stem cells $x Research $x Law and legislation $z European Union countries. $3 2210285
650 0 $a Embryonic stem cells $x Research $x Law and legislation $z United States. $3 2210286
650 1 4 $a Law. $3 600858
650 2 4 $a Medical Law. $3 897066
650 2 4 $a International IT and Media Law, Intellectual Property Law. $3 1568595
650 2 4 $a Bioethics. $3 558486
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-2101-5
950 $a Law and Criminology (Springer-41177)